STOCK TITAN

IM Cannabis Announces Intention to Complete 3:1 Share Consolidation to Support Nasdaq Minimum Bid Price Compliance

(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Rhea-AI Summary

IM Cannabis (IMCC) approved a 1-for-3 reverse share split that the company expects to take effect on November 23, 2026. Split-adjusted trading is expected to begin at the Nasdaq Capital Market open that day, subject to final Nasdaq confirmation and completion of implementation steps. Outstanding common shares are expected to fall from 1,844,162 to approximately 614,721, subject to rounding.

The company said the split is intended to raise the per-share trading price to help maintain compliance with Nasdaq's US$1.00 minimum bid price. Because IM Cannabis completed a 30-for-1 share consolidation on August 27, 2026, it would not qualify for the usual 180-calendar-day compliance period if its closing bid stayed below US$1.00 for 30 consecutive business days. Nasdaq staff would then issue a delisting determination.

Loading...
Loading translation...
0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • None.

Negative

  • Major point. Forward-looking: it has not happened yet and may not happen.Nasdaq delisting determination would follow 30 consecutive business days with a closing bid below US$1.00, without the usual 180-calendar-day compliance period.
  • Minor point. Forward-looking: it has not happened yet and may not happen.1-for-3 reverse split to support Nasdaq compliance is expected November 23, 2026, reducing outstanding common shares from 1,844,162 to approximately 614,721, subject to rounding.
  • Minor pointSplit-adjusted trading still requires final Nasdaq confirmation and completion of corporate, transfer agent and market implementation steps.

News Explained

Outstanding convertible, exchangeable and exercisable securities will have their share counts and exercise or conversion prices adjusted if the consolidation takes effect.

The board has approved a consolidation of three existing shares into one, currently expected to take effect on November 23, 2026; fractional entitlements below one-half share will be canceled, while those of at least one-half share will be rounded up.

If completed, the share counts and exercise or conversion prices for outstanding convertible, exchangeable or exercisable securities will be proportionately adjusted under their terms.

Argus 15 min delay 6 alerts
+6.26% vs previous close $0.5246 last price 3.3x rel. volume Open Argus
Details

Market move: IMCC +6.26% vs previous close. 3:1 share consolidation

+1.7% Peak in 12 min
$0.48 – $0.55 Day Range
$967,448 Mkt Cap at Last Price

On Nov 18, the day this news came out, the latest delayed price for IMCC is 6.26% above the previous close. Argus tracked a peak move of +1.7% during the session. Our momentum scanner has recorded 6 alerts for this stock so far that day. The latest delayed price is $0.52. Relative volume is very high at 3.3x what this stock usually trades by this time of day.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Key Figures

Consolidation ratio: 1 post-consolidated share for every 3 pre-consolidated shares Expected effective date: November 23, 2026 Expected shares outstanding: From 1,844,162 to approximately 614,721 shares +5 more
Consolidation ratio
1 post-consolidated share for every 3 pre-consolidated shares
Board-approved 3:1 share consolidation
Expected effective date
November 23, 2026
Subject to completion of applicable processes
Expected shares outstanding
From 1,844,162 to approximately 614,721 shares
After consolidation; subject to fractional-share rounding
Nasdaq minimum bid requirement
US$1.00 per share
Continued-listing requirement
Prior share consolidation
30:1
Effected August 27, 2026
Bid-price deficiency threshold
Below US$1.00 for 30 consecutive business days
Would make the company ineligible for a compliance period and trigger a Staff Delisting Determination
Ordinary compliance period
180 calendar days
Not available to a company that effected a reverse share split during the prior one-year period
Prior daily close
$0.4937
November 17, before this announcement

Historical Context

1 past event · Latest: Sep 23
1 event
  1. Sep 23

    Nasdaq compliance

    24h Move
    +9.3%

    Nasdaq confirmed compliance after the closing bid stayed at least $1.00 for 18 consecutive business days.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

cusip, isin, staff delisting determination, direct registration system
4 terms
cusip financial
"the CUSIP and ISIN of the Common Shares will be changed"
A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.
View in glossary
isin financial
"the CUSIP and ISIN of the Common Shares will be changed"
A 12-character International Securities Identification Number (ISIN) is a unique code that acts like a passport for a specific stock, bond or other tradable security so it can be identified worldwide. Investors and systems use it to ensure they are buying, selling and tracking the exact same instrument across exchanges and data feeds, which prevents costly mix-ups and makes portfolio reporting, settlement and regulatory checks simpler and more reliable.
View in glossary
staff delisting determination regulatory
"Nasdaq Staff would issue a Staff Delisting Determination"
A staff delisting determination is a formal finding by exchange or regulatory staff that a listed security no longer meets the rules required to stay listed, similar to an official notice that a rental property no longer qualifies for occupancy. It matters to investors because it often precedes removal from the exchange, which can sharply reduce a stock’s visibility, trading liquidity and value, and may trigger urgent choices like selling, appealing the decision or seeking alternative markets.
direct registration system financial
"direct registration system statement representing pre-consolidated Common Shares"
A direct registration system allows investors to register their ownership of securities directly with the issuing company or its transfer agent, rather than holding shares through a broker or intermediary. This setup gives investors more control over their holdings and simplifies the process of buying or selling shares. It is important because it can reduce costs, increase transparency, and provide a clearer record of ownership.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

VANCOUVER and GLIL YAM, Israel, Nov. 18, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel, announces that the board of directors of the Company (the "Board") has approved a consolidation of its issued and outstanding common shares, no par value per share ("Common Shares") on the basis of one post-consolidated Common Share for every three pre-consolidated Common Shares (the "Consolidation").

The Board has authorized the Consolidation to be effected, with the Company currently expecting November 23, 2026 to be the effective date of the Consolidation (the "Effective Date"). The Company anticipates that the Common Shares will begin trading on the Nasdaq Capital Market ("Nasdaq") on a post-Consolidation basis at the opening of trading on November 23, 2026, subject to final confirmation from Nasdaq and completion of applicable corporate, transfer agent and market implementation processes.

Upon the completion of the Consolidation, the CUSIP and ISIN of the Common Shares will be changed to 44969Q604 and CA44969Q6040, respectively. The Company's name and existing stock symbol "IMCC" will remain unchanged.

After giving effect to the Consolidation, the issued and outstanding Common Shares are expected to be reduced from 1,844,162 Common Shares to approximately 614,721 Common Shares, subject to rounding for fractional Common Shares. No fractional Common Shares will be issued in connection with the Consolidation. Instead, all fractional Common Shares equal to or greater than one-half resulting from the Consolidation will be rounded to the next whole number, otherwise, the fractional Common Share will be cancelled. The exercise price and/or conversion price and the number of Common Shares issuable under the Company's outstanding convertible, exchangeable or exercisable securities will be proportionately adjusted in connection with the Consolidation in accordance with their respective terms.

The primary purpose of the Consolidation is to increase the per-share trading price of the Common Shares in an effort to support the Company's efforts to maintain compliance with Nasdaq's US$1.00 minimum bid price requirement for continued listing. Under Nasdaq Listing Rule 5810(c)(3)(A), a company that fails to satisfy Nasdaq's US$1.00 minimum bid price requirement is ordinarily afforded a 180-calendar-day compliance period. However, under Nasdaq Listing Rule 5810(c)(3)(A)(iv), a company is not eligible for that compliance period if it has effected a reverse share split during the prior one-year period. On August 27, 2026, the Company effected a 30:1 share consolidation. Accordingly, if the closing bid price of the Common Shares is below US$1.00 per share for 30 consecutive business days, the Company would not be eligible for a compliance period and Nasdaq Staff would issue a Staff Delisting Determination with respect to the Common Shares. There can be no assurance that the Consolidation will result in the Company maintaining compliance with Nasdaq's continued listing requirements or that the Company will otherwise maintain the listing of its Common Shares on Nasdaq.

Registered shareholders as of the Effective Date will receive a letter of transmittal from Computershare Investor Services Inc., the Company's registrar and transfer agent for its Common Shares, providing instructions for the exchange of their Common Shares as soon as practicable following the Effective Date. Registered shareholders may also obtain a copy of the letter of transmittal by accessing the Company's SEDAR+ profile at www.sedarplus.ca. Until surrendered, each share certificate or direct registration system statement representing pre-consolidated Common Shares will represent the number of whole post-consolidated Common Shares to which the holder is entitled as a result of the Consolidation. No action is required by beneficial holders to receive post-consolidation Common Shares in connection with the Consolidation. Beneficial shareholders who hold their Common Shares through intermediaries (e.g., a broker, bank, trust company, investment dealer or other financial institution) and who have questions regarding how the Consolidation will be processed should contact their intermediaries with respect to the Consolidation.

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) is an international company currently operating a medical cannabis platform serving patients in Israel.

The IMC ecosystem operates in Israel through its subsidiaries, which import and distribute cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies and online platforms in Israel that enable the safe delivery and quality control of IMC products throughout the value chain.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking information and forward-looking statements within the meaning of applicable Canadian and United States securities laws (collectively, "forward-looking statements"). Forward-looking statements are based on expectations, estimates, projections and interpretations as at the date of this press release and are often, but not always, identified by words and phrases such as "anticipate", "believe", "expect", "intend", "may", "plan", "should", "will", "would", "could", "estimate", "target", "subject to", "scheduled", "currently expects" and similar words or expressions.

Forward-looking statements in this press release include, without limitation, statements regarding the Consolidation, including the expected completion of the Consolidation, the Consolidation ratio, the expected Effective Date, the anticipated date on which the Common Shares will begin trading on a post-Consolidation basis on Nasdaq, the expected change to the CUSIP and ISIN numbers of the Common Shares, the expected number of Common Shares outstanding following completion of the Consolidation, the treatment of fractional Common Shares, proportionate adjustments to the exercise price and/or conversion price and number of Common Shares issuable under outstanding convertible, exchangeable or exercisable securities of the Company, the Company's expectation that the Consolidation will increase the per-share trading price of the Common Shares, the Company's intention and ability to maintain compliance with Nasdaq's US$1.00 minimum bid price requirement and maintain the listing of the Common Shares on Nasdaq, the timing and outcome of Nasdaq, DTC, transfer agent, corporate and other implementation processes, and the timing and process for exchanging certificates or direct registration system statements representing pre-Consolidation Common Shares.

Forward-looking statements are based on a number of assumptions, including, without limitation, that the Consolidation will be completed on the anticipated terms and timeline; that all required corporate, regulatory, Nasdaq, DTC, transfer agent and other confirmations, approvals, filings, notices or processes will be obtained, made or completed when expected; that the Common Shares will begin trading on a post-Consolidation basis on Nasdaq on the anticipated date; that the Consolidation will result in an increase in the per-share trading price of the Common Shares; that the trading price of the Common Shares will be sufficient for the Company to maintain compliance with Nasdaq's US$1.00 minimum bid price requirement; that Nasdaq will confirm compliance if the applicable requirements are met; that market conditions and trading activity will not materially impair the Company's ability to maintain compliance with Nasdaq's continued listing requirements; and that there will be no material adverse change in the Company's business, operations, capital, financial condition, prospects or regulatory status.

Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or developments to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, without limitation: the risk that the Consolidation may not be completed on the anticipated timeline or at all; the risk that required confirmations, approvals, filings, notices or processes may be delayed, withheld, conditional or not completed as expected; the risk that the Common Shares may not begin trading on a post-Consolidation basis on the anticipated date; the risk that the Consolidation may not result in a sustained increase in the per-share trading price of the Common Shares; the risk that the Company may not maintain compliance with Nasdaq's US$1.00 minimum bid price requirement or other continued listing requirements, which could result in delisting; volatility and liquidity risks affecting the Common Shares; risks relating to the adjustment of convertible, exchangeable or exercisable securities; risks relating to communications with, and the exchange process for, registered and beneficial shareholders; regulatory, licensing and governmental policy risks in the jurisdictions where the Company operates; any unexpected failure to maintain in good standing or renew required licences; the ability of the Company and its subsidiaries (the "Group") to deliver on their sales commitments or growth objectives; reliance on third-party supply agreements and key personnel; the Group's ability to fulfill its obligations; the Group's possible exposure to liability and the anticipated outcome of litigation, disputes or legal proceedings involving the Group; the impact of increasing competition; the availability of merger and acquisition opportunities; adverse market conditions and supply chain constraints; uncertainty regarding production quantities, quality and cost estimates and the potential for unexpected costs and expenses; product liability and other safety-related liability arising from the use of the Group's products; debt default risk; risks arising from war, conflict and civil unrest in Eastern Europe and the Middle East, including the impact of the multi-front war Israel is facing on the Company, its operations and the medical cannabis industry in Israel; risks related to the Company's focus on the markets in which it operates; the Company's ability to achieve sustainable profitability, increase shareholder value, manage costs, improve margins, grow or maintain sales, meet its goals and strategic plans, reduce costs or maintain revenues, and take advantage of the legalization of medical cannabis in certain jurisdictions; and the other risks, uncertainties and factors set out under "Risk Factors" in the Company's annual report for the year ended December 31, 2025, available on SEDAR+ at www.sedarplus.ca and EDGAR at www.sec.gov/edgar.

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management as of such date. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. The forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Michal Efraty
Investor & Public Relations
IM Cannabis Corp.
michal@efraty.com

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
info@imcannabis.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/im-cannabis-announces-intention-to-complete-31-share-consolidation-to-support-nasdaq-minimum-bid-price-compliance-302944222.html

SOURCE IM Cannabis Corp.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is the IM Cannabis reverse split expected to take effect, and what is the ratio?

IM Cannabis expects its 1-for-3 reverse split to take effect November 23, 2026. Split-adjusted trading is expected to begin at the Nasdaq Capital Market open that day, subject to final Nasdaq confirmation and completion of implementation steps.

Do IM Cannabis shareholders need to do anything for the reverse split?

Registered shareholders should follow the exchange instructions in the letter of transmittal, while shareholders who hold through a broker or other intermediary do not need to act. Computershare Investor Services will send the letter to shareholders registered on the effective date as soon as practicable afterward. It will also be available on the company's SEDAR+ profile.

How will IM Cannabis handle fractional shares in the reverse split?

IM Cannabis will round fractions of one-half share or more up to the next whole share and cancel fractions below one-half. No fractional shares will be issued.

Keep reading